Connection

WILLIAM MITCH to Proteasome Endopeptidase Complex

This is a "connection" page, showing publications WILLIAM MITCH has written about Proteasome Endopeptidase Complex.
  1. Inhibition of Stat3 activation suppresses caspase-3 and the ubiquitin-proteasome system, leading to preservation of muscle mass in cancer cachexia. J Biol Chem. 2015 Apr 24; 290(17):11177-87.
    View in: PubMed
    Score: 0.434
  2. Mechanisms stimulating muscle wasting in chronic kidney disease: the roles of the ubiquitin-proteasome system and myostatin. Clin Exp Nephrol. 2013 Apr; 17(2):174-82.
    View in: PubMed
    Score: 0.373
  3. Proteolysis by the ubiquitin-proteasome system and kidney disease. J Am Soc Nephrol. 2011 May; 22(5):821-4.
    View in: PubMed
    Score: 0.331
  4. Ubiquitin, proteasomes and proteolytic mechanisms activated by kidney disease. Biochim Biophys Acta. 2008 Dec; 1782(12):795-9.
    View in: PubMed
    Score: 0.275
  5. Muscle wasting in chronic kidney disease: the role of the ubiquitin proteasome system and its clinical impact. Pediatr Nephrol. 2008 Apr; 23(4):527-35.
    View in: PubMed
    Score: 0.261
  6. Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling. Endocrinology. 2006 Sep; 147(9):4160-8.
    View in: PubMed
    Score: 0.237
  7. Protein degradation by the ubiquitin-proteasome pathway in normal and disease states. J Am Soc Nephrol. 2006 Jul; 17(7):1807-19.
    View in: PubMed
    Score: 0.236
  8. Parathyroid hormone stimulates adipose tissue browning: a pathway to muscle wasting. Curr Opin Clin Nutr Metab Care. 2017 May; 20(3):153-157.
    View in: PubMed
    Score: 0.126
  9. Caspase-3 cleaves specific 19 S proteasome subunits in skeletal muscle stimulating proteasome activity. J Biol Chem. 2010 Jul 09; 285(28):21249-57.
    View in: PubMed
    Score: 0.077
  10. Review of muscle wasting associated with chronic kidney disease. Am J Clin Nutr. 2010 Apr; 91(4):1128S-1132S.
    View in: PubMed
    Score: 0.076
  11. Malnutrition is an unusual cause of decreased muscle mass in chronic kidney disease. J Ren Nutr. 2007 Jan; 17(1):66-9.
    View in: PubMed
    Score: 0.061
  12. Proteolytic mechanisms, not malnutrition, cause loss of muscle mass in kidney failure. J Ren Nutr. 2006 Jul; 16(3):208-11.
    View in: PubMed
    Score: 0.059
  13. Cellular signals activating muscle proteolysis in chronic kidney disease: a two-stage process. Int J Biochem Cell Biol. 2005 Oct; 37(10):2147-55.
    View in: PubMed
    Score: 0.056
  14. Strategies for suppressing muscle atrophy in chronic kidney disease: mechanisms activating distinct proteolytic systems. J Ren Nutr. 2005 Jan; 15(1):23-7.
    View in: PubMed
    Score: 0.054
  15. Cellular mechanisms causing loss of muscle mass in kidney disease. Semin Nephrol. 2004 Sep; 24(5):484-7.
    View in: PubMed
    Score: 0.052
  16. Regulation of muscle protein degradation: coordinated control of apoptotic and ubiquitin-proteasome systems by phosphatidylinositol 3 kinase. J Am Soc Nephrol. 2004 Jun; 15(6):1537-45.
    View in: PubMed
    Score: 0.051
  17. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest. 2004 Jan; 113(1):115-23.
    View in: PubMed
    Score: 0.050
  18. Mechanisms activating proteolysis to cause muscle atrophy in catabolic conditions. J Ren Nutr. 2003 Apr; 13(2):149-52.
    View in: PubMed
    Score: 0.047
  19. Myostatin/activin pathway antagonism: molecular basis and therapeutic potential. Int J Biochem Cell Biol. 2013 Oct; 45(10):2333-47.
    View in: PubMed
    Score: 0.024
  20. Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle. Kidney Int. 2002 Apr; 61(4):1286-92.
    View in: PubMed
    Score: 0.011
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.